PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65
- PMID: 22724072
- PMCID: PMC3376738
- DOI: 10.1098/rsob.120080
PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65
Abstract
Missense mutations in PTEN-induced kinase 1 (PINK1) cause autosomal-recessive inherited Parkinson's disease (PD). We have exploited our recent discovery that recombinant insect PINK1 is catalytically active to test whether PINK1 directly phosphorylates 15 proteins encoded by PD-associated genes as well as proteins reported to bind PINK1. We have discovered that insect PINK1 efficiently phosphorylates only one of these proteins, namely the E3 ligase Parkin. We have mapped the phosphorylation site to a highly conserved residue within the Ubl domain of Parkin at Ser(65). We show that human PINK1 is specifically activated by mitochondrial membrane potential (Δψm) depolarization, enabling it to phosphorylate Parkin at Ser(65). We further show that phosphorylation of Parkin at Ser(65) leads to marked activation of its E3 ligase activity that is prevented by mutation of Ser(65) or inactivation of PINK1. We provide evidence that once activated, PINK1 autophosphorylates at several residues, including Thr(257), which is accompanied by an electrophoretic mobility band-shift. These results provide the first evidence that PINK1 is activated following Δψm depolarization and suggest that PINK1 directly phosphorylates and activates Parkin. Our findings indicate that monitoring phosphorylation of Parkin at Ser(65) and/or PINK1 at Thr(257) represent the first biomarkers for examining activity of the PINK1-Parkin signalling pathway in vivo. Our findings also suggest that small molecule activators of Parkin that mimic the effect of PINK1 phosphorylation may confer therapeutic benefit for PD.
Keywords: PINK1; Parkin; Parkinson's disease.
Figures
Similar articles
-
N-degron-mediated degradation and regulation of mitochondrial PINK1 kinase.Curr Genet. 2020 Aug;66(4):693-701. doi: 10.1007/s00294-020-01062-2. Epub 2020 Mar 10. Curr Genet. 2020. PMID: 32157382 Review.
-
Binding to serine 65-phosphorylated ubiquitin primes Parkin for optimal PINK1-dependent phosphorylation and activation.EMBO Rep. 2015 Aug;16(8):939-54. doi: 10.15252/embr.201540352. Epub 2015 Jun 25. EMBO Rep. 2015. PMID: 26116755 Free PMC article.
-
The three 'P's of mitophagy: PARKIN, PINK1, and post-translational modifications.Genes Dev. 2015 May 15;29(10):989-99. doi: 10.1101/gad.262758.115. Genes Dev. 2015. PMID: 25995186 Free PMC article. Review.
-
Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65.Biochem J. 2014 May 15;460(1):127-39. doi: 10.1042/BJ20140334. Biochem J. 2014. PMID: 24660806 Free PMC article.
-
Parkin-catalyzed ubiquitin-ester transfer is triggered by PINK1-dependent phosphorylation.J Biol Chem. 2013 Jul 26;288(30):22019-32. doi: 10.1074/jbc.M113.467530. Epub 2013 Jun 10. J Biol Chem. 2013. PMID: 23754282 Free PMC article.
Cited by
-
KAT8 compound inhibition inhibits the initial steps of PINK1-dependant mitophagy.Sci Rep. 2024 May 22;14(1):11721. doi: 10.1038/s41598-024-60602-9. Sci Rep. 2024. PMID: 38777823 Free PMC article.
-
PRKN-linked familial Parkinson's disease: cellular and molecular mechanisms of disease-linked variants.Cell Mol Life Sci. 2024 May 20;81(1):223. doi: 10.1007/s00018-024-05262-8. Cell Mol Life Sci. 2024. PMID: 38767677 Free PMC article. Review.
-
Pharmacological PINK1 activation ameliorates Pathology in Parkinson's Disease models.Res Sq [Preprint]. 2024 May 10:rs.3.rs-4356493. doi: 10.21203/rs.3.rs-4356493/v1. Res Sq. 2024. PMID: 38765977 Free PMC article. Preprint.
-
Mitophagy in health and disease. Molecular mechanisms, regulatory pathways, and therapeutic implications.Apoptosis. 2024 May 17. doi: 10.1007/s10495-024-01977-y. Online ahead of print. Apoptosis. 2024. PMID: 38758472 Review.
-
The role of mitophagy in the development of chronic kidney disease.PeerJ. 2024 Apr 25;12:e17260. doi: 10.7717/peerj.17260. eCollection 2024. PeerJ. 2024. PMID: 38680884 Free PMC article. Review.
References
-
- Muqit MM, et al. 2006. Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress. J. Neurochem. 98, 156–16910.1111/j.1471-4159.2006.03845.x (doi:10.1111/j.1471-4159.2006.03845.x) - DOI - DOI - PubMed
-
- Valente EM, et al. 2004. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158–116010.1126/science.1096284 (doi:10.1126/science.1096284) - DOI - DOI - PubMed
-
- Woodroof HI, et al. 2011. Discovery of catalytically active orthologues of the Parkinson's disease kinase PINK1: analysis of substrate specificity and impact of mutations. Open Biol. 1, 110012.10.1098/rsob.110012 (doi:10.1098/rsob.110012) - DOI - DOI - PMC - PubMed
-
- Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, Seol JH, Yoo SJ, Hay BA, Guo M. 2006. Drosophila PINK1 is required for mitochondrial function and interacts genetically with Parkin. Nature 441, 1162–116610.1038/nature04779 (doi:10.1038/nature04779) - DOI - DOI - PubMed
-
- Park J, et al. 2006. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by Parkin. Nature 441, 1157–116110.1038/nature04788 (doi:10.1038/nature04788) - DOI - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials